A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells
PLOS ONE · 10.05.2023 · 18 (5) · e0274065
DOI: 10.1371/journal.pone.0274065 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 10.05.2023. Verfasst von Timothy K Soh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Structural Systems Biology, Hamburg, Germany. Hauptthemen laut MEDLINE: COVID-19, Herpesviridae. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Downstream analysis of virus-infected cell samples, such as reverse transcription polymerase chain reaction (RT PCR) or mass spectrometry, often needs to be performed at lower biosafety levels than their actual cultivation, and thus the samples require inactivation before they can be transferred. Common inactivation methods involve chemical crosslinking with formaldehyde or denaturing samples with strong detergents, such as sodium dodecyl sulfate. However, these protocols destroy the protein quaternary structure and prevent the analysis of protein complexes, albeit through different chemical mechanisms. This often leads to studies being performed in over-expression or surrogate model systems. To address this problem, we generated a protocol that achieves the inactivation of infected cells through ultraviolet (UV) irradiation. UV irradiation damages viral genomes and crosslinks nucleic acids to proteins but leaves the overall structure of protein complexes mostly intact. Protein analysis can then be performed from intact cells without biosafety containment. While UV treatment protocols have been established to inactivate viral solutions, a protocol was missing to inactivate crude infected cell lysates, which heavily absorb light. In this work, we develop and validate a UV inactivation protocol for SARS-CoV-2, HSV-1, and HCMV-infected cells. A fluence of 10,000 mJ/cm 2 with intermittent mixing was sufficient to completely inactivate infected cells, as demonstrated by the absence of viral replication even after three sequential passages of cells inoculated with the treated material. The herein described protocol should serve as a reference for inactivating cells infected with these or similar viruses and allow for the analysis of protein quaternary structure from bona fide infected cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Structural Systems Biology, Hamburg, Germany.
- Hannover Medical School, Institute of Virology, Hannover, Germany.
- Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
- Leibniz Institute of Virology (LIV), Hamburg, Germany.
- Department of Virology, Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany.
- Virology and Hygiene, Institute for Medical Microbiology, University Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
ORCID-Profile: Ronald von Possel, Maria Rosenthal, Jens B Bosse
Förderung
- Wellcome Trust
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Soh, T. K., Pfefferle, S., Wurr, S., von Possel, R., Oestereich, L., Rieger, T., Uetrecht, C., Rosenthal, M., & Bosse, J. B. (2023). A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells. PLOS ONE, 18(5), e0274065. https://doi.org/10.1371/journal.pone.0274065
Vancouver
Soh TK, Pfefferle S, Wurr S, von Possel R, Oestereich L, Rieger T, et al. A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells. PLOS ONE. 2023;18(5):e0274065. doi:10.1371/journal.pone.0274065
BibTeX
@article{Soh2023,
author = {Soh, Timothy K and Pfefferle, Susanne and Wurr, Stephanie and von Possel, Ronald and Oestereich, Lisa and Rieger, Toni and Uetrecht, Charlotte and Rosenthal, Maria and Bosse, Jens B},
title = {A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {5},
pages = {e0274065},
doi = {10.1371/journal.pone.0274065}
}
EUVIMED